This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
This product is temporarily unavailable.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Healthylife.com.au is a and private sales and supply company. While it is a private company, it is not licensed to hold the approval and sale of any kind of product without specific consultation with a licensed pharmacist or physician from a certain country. Healthylife.com.au is based in Tempe, Arizona and has been in business since the late 1990s. It is a non-prescription product that requires a prescription in Australia only. If you are experiencing a wellness concerns, please consult your doctor or pharmacist. Healthylife.com.au temporarily stop providing this information. Giulian Pharmacy is a licensed pharmacy that sells genuine generic medicine. Not suitable for everyoneIntroduction:Aromatase inhibitors (AIs) are a type of drug used to reduce the risk of breast cancer in women. They are available as an orally administered drug and are generally considered safe for use. We compared the safety and efficacy of Arimidex and Aromasin in a prospective, double-blind, placebo-controlled, multicenter, randomized study comparing Arimidex and Aromasin in premenopausal and postmenopausal women with stage II-III breast cancer. In this multicenter, prospective, randomized, parallel-group, placebo-controlled study, we assessed the efficacy and tolerability of Arimidex (n=14) and Aromasin (n=14) in a prospective, double-blinded, randomized, placebo-controlled, multicenter study comparing Arimidex and Aromasin in postmenopausal and premenopausal women with stage II-III breast cancer, as well as in postmenopausal women with stage III-IV breast cancer. A total of 546 patients were randomized to Arimidex (n=146) or Aromasin (n=154) (Arimidex was not included in the study because of lack of data from patients receiving Arimidex; Aromasin was not included in the study because of lack of data from patients receiving Arimidex; both study populations were postmenopausal women with node-negative disease). Arimidex was well tolerated in all patients, with a similar incidence of 1.7% in patients receiving Arimidex versus 0.6% in those receiving Aromasin. The incidence of breast cancer recurrence or progression in patients receiving Arimidex was significantly higher than that in patients receiving Aromasin (7.6% versus 3.3%, respectively; 95% confidence interval [CI] = 3.1–9.1%; p=0.006). The overall survival rate was significantly lower in patients with node-negative disease who received Arimidex (5.8 versus 4.6, respectively; 95% CI 1.5–9.4; p<0.001). The incidence of breast cancer recurrence or progression was not significantly different between the two groups.
Aromatase inhibitors are indicated for the treatment of hormone receptor-positive breast cancer (HR-AB) in postmenopausal women. Breast cancer is a frequent cause of cancer death in postmenopausal women, with an approximately two-thirds of cases developing in postmenopausal women at some point in their lives. Breast cancer is the main cause of death in the United States, with an estimated 3.5 million women dying of breast cancer each year. There is a small number of women who can develop breast cancer after menopause, and about half of women will die from it. The National Comprehensive Cancer Network (NCCN) recommends that all women with breast cancer receive a therapy that is free of charge and that provides a five-year survival rate of approximately 25%–50%. The American Cancer Society recommends that the cost of therapy with an aromatase inhibitor be $1,000–$5,000 per patient per year and that women should receive a therapy that provides a five-year survival rate of approximately 10–15%. An aromatase inhibitor is not a cure for HR-AB, but it can help reduce the risk of recurrence and progression. Aromatase inhibitors are not indicated for the treatment of primary breast cancer, and they are not recommended for the treatment of HR-AB. Arimidex was shown to be safe and well tolerated in a Phase II trial to date. Aromasin is generally well tolerated. Arimidex has been used to reduce the risk of breast cancer recurrence in HR-AB and is generally well tolerated in postmenopausal women. Aromasin was not as effective as Arimidex in reducing the risk of recurrence or progression in HR-AB in patients with stage II-III breast cancer. The incidence of breast cancer recurrence or progression in patients with postmenopausal women with HR-AB is significantly lower than that of patients with stage II-III breast cancer.
Breast cancer is the main cause of cancer death in postmenopausal women, with an approximately two-thirds of cases developing in postmenopausal women at some point in their lives.
What is Arimidex? Arimidex, also known as Anastrozole in the field of medical science, is a medication commonly used to treat breast cancer. It belongs to a class of drugs known as aromatase inhibitors. Arimidex works by reducing the amount of estrogen in the body, which helps to slow the growth of hormone receptor-positive breast cancer cells. Arimidex is typically prescribed in conjunction with other therapies to manage the side effects of hormone therapy and to lower the chances of recurrence. In some cases, Arimidex may also be used to treat hormone receptor-positive breast cancer, a type of cancer that has spread beyond the breastbone.
Arimidex is a medication that is used to treat breast cancer. It is a type of medication that is derived from a natural substance, which is derived from the urine of an animal. This makes it effective in reducing the chances of recurrence. Arimidex is also effective in controlling the growth of hormone receptor-positive breast cancer cells, making it a popular choice among patients and healthcare providers.
To maximize the effectiveness of Arimidex, it is crucial to follow the dosage instructions provided by your healthcare provider. It is recommended to take Arimidex at the same time each day to maintain its effects. It is important to complete the full course of treatment even if you start feeling better before finishing it. Arimidex is typically taken once a day, regardless of whether you are taking it on an empty stomach or with food. However, if you are on Arimidex and you experience any severe side effects, it is important to consult with your healthcare provider before starting treatment. They may adjust the dosage or recommend alternative treatments to help minimize the risk of recurrence.
The common side effects of Arimidex include hot flashes, mood swings, and nausea. It is important to report any changes in your medical condition or medication to your healthcare provider promptly. Some common side effects of Arimidex include breast pain, fluid retention, or swelling in your breasts. Some side effects of Arimidex can be mild or severe, and it is important to be aware of them if they become bothersome or do not go away. In rare cases, more serious side effects such as liver damage or allergic reactions can occur. If you experience any severe or persistent side effects, it is important to seek medical attention.
It is important to inform your healthcare provider of any existing medical conditions or medications you are taking. It is not recommended to take Arimidex if you are pregnant, breastfeeding, or have liver disease. Inform your healthcare provider about any medications you are currently taking to prevent interactions. If you have a history of blood clots, have had a stroke, or if you are currently pregnant or are planning to become pregnant, it is important to inform your healthcare provider of all medications you are currently taking. It is not recommended to take Arimidex if you are currently taking any of the following medications: anticoagulants ('blood thinners') such as warfarin (Coumadin), selective serotonin reuptake inhibitors (SSRIs) such as fluconazole (Dafconazole), and lithium (Erythromycin).
If you are allergic to Arimidex or any other ingredients in Arimidex, it is important to inform your healthcare provider of any of the medications you are currently taking. In particular, it is important to inform your healthcare provider if you have had an allergic reaction to any of the following medications: penciclovir (Herceptin) or other medications for anxiety or depression (such as Atacand), metformin (Glucophage), oral corticosteroids (such as prednisone), or thiazide diuretics ('diuretics') such as amiloride (Amiloride) or trilostazol (Flutamide).
If you are taking Arimidex, it is important to inform your healthcare provider of any of the following information.
Q: Does ARIMIDEX 1MG TABLET affect bone health?
A: Yes, ARIMIDEX 1MG TABLET acts by lowering the estrogen levels in the body, which is an important hormone to maintain bone health. Due to this, the mineral content of the bones decreases, and they may become less strong and more prone to fracture. Your doctor might ask you to take several tests to better assess and manage your condition.
Q: Can I stop taking ARIMIDEX 1MG TABLET on my own?
A: No, do not stop taking ARIMIDEX 1MG TABLET without the advice of your doctor. However, not taking the medicine at the recommended time may increase the risk of your breast cancer recurring.
Q: Is ARIMIDEX 1MG TABLET a form of chemotherapy?
A: No, ARIMIDEX 1MG TABLET acts by decreasing the estrogen levels in the body, which is a hormone. This in turn decreases the growth of cancer cells in breasts. ARIMIDEX 1MG TABLET is hormone therapy.
Q: Who should avoid taking ARIMIDEX 1MG TABLET?
A: ARIMIDEX 1MG TABLET is not recommended if you still have menstrual periods, are pregnant or planning to become pregnant, or are allergic to ARIMIDEX 1MG TABLET. Consult your doctor before taking ARIMIDEX 1MG TABLET.
Q: What if I forget to take a dose of ARIMIDEX 1MG TABLET?
A: If you forget to take a dose of ARIMIDEX 1MG TABLET, just take your next dose as normal. Do not take two doses of ARIMIDEX 1MG TABLET at the same time to make up for a forgotten dose.
Q: Can alcohol be consumed with ARIMIDEX 1MG TABLET?
A: It is best to avoid or limit alcohol intake when ARIMIDEX 1MG TABLET is taken, since alcohol can raise your risk of experiencing side effects from ARIMIDEX 1MG TABLET such as hot flashes or joint pain.
Q: Should calcium be taken with ARIMIDEX 1MG TABLET?
A: It is advisable to take calcium and vitamin D supplements while ARIMIDEX 1MG TABLET is taken since the medicine may cause bone loss as a side effect, which can be monitored by a bone mineral density (BMD) test if done every 1 to 2 years.
Q: Is ARIMIDEX 1MG TABLET safe to use with children?
A: ARIMIDEX 1MG TABLET is not recommended for use in children and adolescents under 18 years of age due to a lack of safety and effectiveness. Generally, breast cancer occurs in older women. However, consult your doctor for advice before taking ARIMIDEX 1MG TABLET.
References access privilegesannieUSTREILLE, Tilly PDR, King Pharmaceuticals (India), November 2017 ()About ARIMIDEX 1MG TABLET: A 1mg tablet is a form of estrogen that is mainly used to treat breast cancer. ARIMIDEX 1MG TABLET contains an active ingredient called anastrozole, which works by reducing the production of estrogen in the body. This leads to reduced growth of sensitive types of breast cancer.A: It is advisable to avoid or limit alcohol consumption when ARIMIDEX 1MG TABLET is taken, Since ARIMIDEX 1MG TABLET is hormone therapy, it is usually prescribed when other medications haven't worked. It is best to take ARIMIDEX 1MG TABLET after a meal. Lifestyle changes may also help decrease alcohol intake. It is important to have a doctor's prescription before taking ARIMIDEX 1MG TABLET.
Q: Is ARIMIDEX 1MG TABLET safe to use with children under 18 years of age?
ARIMIDEX 1MG TABLET is usually prescribed when other medications haven't worked.
Stade de France Pharmacy